ACSM3 overexpression
|
Prostate Cancer
|
ACSM3 overexpression
|
Prostate Cancer
|
erastin Resistant: D – Preclinical
|
erastin Resistant: D – Preclinical
|
ACSM3 overexpression
|
Prostate Cancer
|
ACSM3 overexpression
|
Prostate Cancer
|
ML210 Resistant: D – Preclinical
|
ML210 Resistant: D – Preclinical
|